1. Efficacy and safety of dronedarone vs placebo in patients with atrial fibrillation or atrial flutter across a spectrum of renal function: post hoc analyses of the EURIDIS-ADONIS trials. (25th November 2020) Authors: Thind, M; Zareba, W; Atar, D; Crijns, H; Zhu, J; Pak, H.-N; Reiffel, J; Ludwigs, U; Wieloch, M; Stewart, J; Kowey, P Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The impact of dronedarone on patients with atrial fibrillation and diabetes – a sub-analysis of the ATHENA and EURIDIS/ADONIS trials. (14th October 2021) Authors: Handelsman, Y; Steinberg, B; Rodbard, H; Bunch, J; Thind, M; Bigot, G; Konigsberg, L; Wieloch, M; Bhattacharyya, N; Kowey, P Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗